A study comparing the usefulness of Candida albicans antigen with MMR injection in skin warts.
Not Applicable
Completed
- Conditions
- Health Condition 1: B07- Viral warts
- Registration Number
- CTRI/2020/06/026098
- Lead Sponsor
- Dr JEMSHI S RAHIM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Patients with multiple cutaneous extragenital
warts (more than 3 warts) presenting to department of Dermatology
of AIIMS, Raipur, within the study period, who gives consent to
participate.
Exclusion Criteria
1.Pregnant and lactating ladies
2.Those with uncontrolled urticaria
3.Active candidiasis
4.Uncontrolled asthma
5.Known severe hypersensitivity to Candida albicans antigen or MMR
vaccine
6.Acute febrile illness
7.Those receiving concomitant other treatments for warts
8.Immunosuppressed patients with Human Immunodeficiency Virus (HIV)
infection, diabetes, post-splenectomy patients.
9.Patients on immunosuppressive drugs like corticosteroids
10.Past history of meningitis or convulsions
11.Patients with only oral mucosal, genital, and plane warts.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method